As the State sponsor we invite registered delegates to consider attending some of the Victorian Government organised Biofest events.

1. The State of Victoria welcomes all the Biofest 2016 delegates to Melbourne
and hope you enjoy your time at the conference. We also hope you take
the opportunity to explore many of the experiences that Melbourne has
to offer visitors.
As the State sponsor we invite registered delegates to consider attending
some of the Victorian Government organised Biofest events:
MONDAY
24OCT
Opening Plenary Session.
Conference opening by the Premier of Victoria,
The Hon Daniel Andrews MP
9am prior Room 203/204 Level 2 Melbourne Convention Centre
MONDAY
24OCT
Collaboration for innovation –
drug development in the modern biopharma era
Melbourne is a leading global location for innovative research capabilities
for pharmaceutical identification, optimization and development.
This session will explore how Australia can capitalise on the need for new
innovation through collaboration and partnering, understand industry
needs and how to better partner with international pharmaceutical companies
Local experts will speakers discuss their approach to translating
basic research and partnering with global pharmaceutical companies,
1:30pm to 3pm Room 207 Melbourne Convention Centre
TUESDAY
25OCT
Clinical Trials and the R&D Tax Credit – Information Session
(use content from previous artwork)
Melbourne is a premier location for clinical trials. Come and learn how
you can benefit from conducting your trial in Victoria. From accessing
the R&D tax credit to Australia’s CTN scheme which provides an
expedited pathway to Phase 1 trials with most able to start within
a week of registration
Local clinical trial experts and leaders with present and answer questions
from 11am to 12:30pm Room 109 Level 1 Melbourne Convention Centre
WEDNESDAY
26OCT
Australia Biotech Invest – Welcome and official opening
Conference opening by
The Minister for Small Business, Innovation and Trade
The Hon Philip Dalidakis
9am to 9:30am Melbourne Convention Centre
AUSBIOTECH
INTERNATIONAL BIOFEST
MELBOURNE, VICTORIA

2. To find out more about opportunities to grow your business or about
Victoria’s biotechnology capabilities we invite all the Biofest 2016
delegates to drop by our stand in the exhibition space. In addition
to Victorian Government staff our exhibition space will have a range
of Victorian co-exhibitors including:
The Victorian Platform Technologies Network (VPTN) – links innovation with technology and
expertise by connecting researchers from industry and academia with research technology
platforms and infrastructure.
BioMedical Research Victoria – representing Victorian universities, teaching hospitals, medical
research institutes, CSIRO and other research organisations, Biomedical Research Victoria seeks
to develop shared vision, long term plans and better links between government, industry and the
biomedical community.
MONDAY
24OCT
BioCurate Pty Ltd – a venture catalyst, it will increase the number, quality
and rate of translation of new drug discoveries into medically sound and
commercially attractive, investable projects
Starpharma – a ASX300 company (ASX:SPL) Starpharma is a world leader
in the development of dendrimer products having three business areas with
products under with products under development and on market
Cancer Therapeutics CRC – finds cures for cancer by translating Australia’s
innovative research discoveries into new drugs ready for clinical development
TUESDAY
25OCT
Australian Regenerative Medicine Institute – Australia’s only institute
specialising in regeneration and stem cells – conducts research investigating
how to harness the body’s potential for self-repair
Victorian Government Coordinating Office for Clinical Trials – The Department
of Health and Human Services Office is responsible for overseeing aspects of
clinical trials in Victorian health services including streamlining ethical review
and research governance requirements
Cynata Therapeutics – ASX-listed company is developing its proprietary
technology Cymerus™ to mass produce mesenchymal stem cell (MSC) therapies,
starting from induced pluripotent stem cells (iPSCs)
Cell Therapies Pty Ltd – the most experienced GMP contract manufacturer in
the APAC region and a recognised leader in distribution of cell-based therapies
WEDNESDAY
26OCT
AdAlta Limited – The proprietary technology platform of Melbourne drug
development company AdAlta Limited (ASX: 1AD) generates i-bodies –
a new class of protein therapeutics to treat disease
The Florey Institute of Neuroscience and Mental Health – the largest brain
research group in the Southern Hemisphere and a world leader in imaging
technology, stroke rehabilitation and epidemiological studies
Burnet Institute – links medical research with practical action to achieve
better health for vulnerable populations in Australia and internationally
through research, education and public health
DEDJTR10305/16
AUSBIOTECH
INTERNATIONAL BIOFEST
MELBOURNE, VICTORIA